Rashtriya Newsflash

Press Release

PITAKA Launches The Ultra-Slim Case for Samsung Galaxy Z Fold7 and Flip7 – A Refreshed Return of the Iconic “Sunset Moment” Colorway

On July 9, 2025, innovative materials technology brand PITAKA officially launched its next-generation flagship product — the Aramid Fiber Ultra-Slim Case for Samsung Galaxy Z Fold7 and Flip7. Available on

Read Full Article

Hohem Unveils Best Gimbal Deals of 2025 Mid-Year Mega Sale

Hohem Unveils Best Gimbal Deals of 2025 Mid-Year Mega Sale — Save Up to 50% on Flagship Models As the 2025 Mid-Year Mega Sale kicks off, Hohem Tech, a global

Read Full Article

Han’s Laser Full Range Handheld Welder Series Makes Global Debut

In recent years, the significant decline in the price of fiber lasers has become a key driving force behind the rapid growth of the handheld laser welder market. Industry data

Read Full Article

NAVIFORCE Launches Its Official Online Store in India, Offering Direct Access to Military-Grade Timepieces

NAVIFORCE offers Military Grade Timepieces by its Official Online Store in India NAVIFORCE has officially launched its online store in India via Secure Space in Hyderabad, providing direct access to

Read Full Article

CDK12 Inhibitor Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Insilico Medicine, Chordia Therapeutics, Carrick Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, CDK12 Inhibitor pipeline constitutes 3+ key companies continuously working towards

Read Full Article

From Rock Bottom to Redemption: New Memoir Starting Over Offers Raw, Unfiltered Look at Addiction and Recovery

Houston, TX – July 9, 2025 – In a world where second chances are rare and redemption stories often feel sugarcoated,

Read Full Article

Diabetic Retinopathy Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | | Kodiak Sciences, Novartis, Regenxbio Inc., OcuTerra Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Retinopathy pipeline constitutes 50+ key companies continuously working towards

Read Full Article

Postoperative Pain Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Allay Therapeutics, SiteOne Therapeutics, LipoCure, Flexion Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Postoperative Pain pipeline constitutes 40+ key companies continuously working towards

Read Full Article

Postpartum Depression Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Postpartum Depression pipeline constitutes 10+ key companies continuously working towards

Read Full Article

Huntington’s Disease Pipeline 2025: MOA, ROA, and Clinical Trial Insights Explored by DelveInsight | Spark therapeutics, Chong Kun Dang Pharma, Neuvivo, UniQure Biopharma, Wave Life Sciences, Novartis

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Huntington’s Disease pipeline constitutes 20+ key companies continuously working towards

Read Full Article